Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

asegua therapeutics llc - ledipasvir (unii: 013te6e4wv) (ledipasvir - unii:013te6e4wv), sofosbuvir (unii: wj6ca3zu8b) (sofosbuvir - unii:wj6ca3zu8b) - ledipasvir and sofosbuvir is indicated for the treatment of adults and pediatric patients 3 years of age and older with chronic hepatitis c virus (hcv) [see dosage and administration (2.2 and 2.3) and clinical studies (14)]: - genotype 1, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis - genotype 1 infection with decompensated cirrhosis, for use in combination with ribavirin - genotype 1 or 4 infection who are liver transplant recipients without cirrhosis or with compensated cirrhosis, for use in combination with ribavirin if ledipasvir and sofosbuvir is administered with ribavirin, the contraindications to ribavirin also apply to this combination regimen. refer to the ribavirin prescribing information for a list of contraindications for ribavirin [see dosage and administration (2.2)] . risk summary if ledipasvir and sofosbuvir is administered with ribavirin, the combination regimen is contraindicated in pregnant women and in men whose female partners are pregnant. refer to the ribavirin

Kenija - angļu - Pharmacy and Poisons Board

sofosbuvir - tablet - each film - coated tablet contains sofosbuvir 400… - sofosbuvir

Īrija - angļu - HPRA (Health Products Regulatory Authority)

as grindeks - oxytocin - solution for injection/infusion - 10 international unit(s)/millilitre - oxytocin

Īrija - angļu - HPRA (Health Products Regulatory Authority)

as grindeks - oxytocin - solution for injection/infusion - 5 international unit(s)/millilitre - oxytocin

Izraēla - angļu - Ministry of Health

eldan electronic instruments co ltd - tetrofosmin - lyophilized powder for solution for injection - tetrofosmin 0.23 mg/vial - technetium (99mtc) tetrofosmin - indicated as an adjunct in the diagnosis and localization of myocardial ischaemia or infarction. myoview is indicated as an adjunct to the initial assessments (e.g. palpation mammography or alternative imaging modalities and/or cytology) in characterisation of malignancy of suspected breast lesions where all these other recommended tests were inconclusive.

Īrija - angļu - HPRA (Health Products Regulatory Authority)

ge healthcare limited - tetrofosmin - kit for radiopharmaceutical preparation - 230 microgram - technetium (99mtc) tetrofosmin

Eiropas Savienība - angļu - EMA (European Medicines Agency)

tmc pharma services ltd. - gadofosveset trisodium - magnetic resonance angiography - contrast media - this medicinal product is for diagnostic use only.ablavar is indicated for contrast-enhanced magnetic resonance angiography (ce-mra) for visualisation of abdominal or limb vessels in adults only, with suspected or known vascular disease.

Īrija - angļu - HPRA (Health Products Regulatory Authority)

ge healthcare as - tetrofosmin - kit for radiopharmaceutical preparation - 230 microgram(s) - technetium (99mtc) compounds; technetium (99mtc) tetrofosmin

Izraēla - angļu - Ministry of Health

gilead sciences israel ltd - ledipasvir; sofosbuvir - film coated tablets - ledipasvir 90 mg; sofosbuvir 400 mg - sofosbuvir and ledipasvir - harvoni is indicated for the treatment of chronic hepatitis c (chc) in adults.

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

gilead sciences (nz) - sofosbuvir 400mg;  ;  ;  ; velpatasvir 100mg;  ;  ;   - tablet - 400mg/100mg - active: sofosbuvir 400mg       velpatasvir 100mg       excipient: copovidone croscarmellose sodium opadry ii pink 85f94644 magnesium stearate microcrystalline cellulose - indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults.